Cited by 91Proteoglycans and glycosaminoglycans researchSpinal Cord Injury ResearchNerve injury and regeneration

The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury

Open access
Tauchi, Ryoji, Imagama, Shiro, Natori, Takamitsu, Ohgomori, Tomohiro, Muramoto, Akio, Shinjo, Ryuichi, Matsuyama, Yukihiro, Ishiguro, Naoki +1 more·2012·Journal of Neuroinflammation

Abstract

BACKGROUND: Chondroitin sulfate proteoglycans are major inhibitory molecules for neural plasticity under both physiological and pathological conditions. The chondroitin sulfate degrading enzyme chondroitinase ABC promotes functional recovery after spinal cord injury, and restores experience-dependent plasticity, such as ocular dominance plasticity and fear erasure plasticity, in adult rodents. These data suggest that the sugar chain in a proteoglycan moiety is essential for the inhibitory activity of proteoglycans. However, the significance of the core protein has not been studied extensively. Furthermore, considering that chondroitinase ABC is derived from bacteria, a mammalian endogenous enzyme which can inactivate the proteoglycans' activity is desirable for clinical use. METHODS: The degradation activity of ADAMTS-4 was estimated for the core proteins of chondroitin sulfate proteoglycans, that is, brevican, neurocan and phosphacan. To evaluate the biological significance of ADMATS-4 activity, an in vitro neurite growth assay and an in vivo neuronal injury model, spinal cord contusion injury, were employed. RESULTS: ADAMTS-4 digested proteoglycans, and reversed their inhibition of neurite outgrowth. Local administration of ADAMTS-4 significantly promoted motor function recovery after spinal cord injury. Supporting these findings, the ADAMTS-4-treated spinal cord exhibited enhanced axonal regeneration/sprouting after spinal cord injury. CONCLUSIONS: Our data suggest that the core protein in a proteoglycan moiety is also important for the inhibition of neural plasticity, and provides a potentially safer tool for the treatment of neuronal injuries.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-9-53

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tauchi, R., Imagama, S., Natori, T., Ohgomori, T., Muramoto, A., Shinjo, R., Matsuyama, Y., Ishiguro, N., & Kadomatsu, K.
Affiliations
  • Nagoya University (JP)
  • Hamamatsu University School of Medicine (JP)
Corresponding author
Kadomatsu, Kenji
Venue
Journal of Neuroinflammation
Published
2012-03-15
Volume
9
Issue
1
Pages
53-53
ISSN
1742-2094 (ISSN-L)
OpenAlex
W2101430926
Cited by
91
References
48
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 6 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 11 · 2017: 6 · 2016: 9 · 2015: 8 · 2014: 10 · 2013: 8 · 2012: 2
FWCI
4.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Nagoya University Repository (NAGOYA Repository) (submittedVersion, cc-by-nc-nd)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology (20390092, 23110002, 18390099)
  • Japan Society for the Promotion of Science (23790360)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Spinal Cord Injury Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
ADAMTS-4, chondroitin sulfate proteoglycans, chondroitinase ABC, spinal cord injury, functional recovery, proteoglycan core protein, brevican, neurocan, phosphacan, neurite outgrowth, axon regeneration, motor recovery, neuroplasticity, spinal cord contusion
MeSH terms
ADAMTS4 Protein, Animals, Animals, Newborn, Astrocytes, Cells, Cultured, Cerebellum, Disease Models, Animal, Female, Gene Expression Regulation, Motor Activity, Neurons, Procollagen N-Endopeptidase, Psychomotor Performance, Spinal Cord Injuries, Neurites, Rats, Sprague-Dawley, Recovery of Function, Rats, ADAM Proteins, Versicans, Receptor-Like Protein Tyrosine Phosphatases, Class 5, Neurocan, Brevican

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review